Abstract:Numerous studies have proved that cell-nonautonomous regulation of neoplastic cells is a distinctive and essential characteristic of tumorigenesis. Two way communications between the tumor and the stroma, or within the tumor significantly influence disease progression and modify treatment responses. In the tumor microenvironment (TME), malignant cells utilize paracrine signaling initiated by adjacent stromal cells to acquire resistance against multiple types of anticancer therapies, wherein extracellular vesicles (EVs) substantially promote such events. EVs are nanoscaled particles enclosed by phospholipid bilayers, and can mediate intercellular communications between cancerous cells and the adjacent microenvironment to accelerate pathological proceeding. Here we review the most recent studies of EV biology and focus on key cell lineages of the TME and their EV cargoes that are biologically active and responsible for cancer resistance, including proteins, RNAs, and other potentially essential components. Since EVs are emerging as novel but critical elements in establishing and maintaining hallmarks of human cancer, timely and insightful understanding of their molecular properties and functional mechanisms would pave the road for clinical diagnosis, prognosis, and effective targeting in the global landscape of precision medicine. Further, we address the potential of EVs as promising biomarkers in cancer clinics and summarize the technical improvements in EV preparation, analysis, and imaging. We highlight the practical issues that should be exercised with caution to guide the development of targeting agents and therapeutic methodologies to minimize cancer resistance driven by EVs, thereby allowing to effectively control the early steps of disease exacerbation.

Tumor-derived Extracellular Vesicles: Regulators of Tumor Microenvironment and the Enlightenment in Tumor Therapy

Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment

Extracellular vesicles in the tumor immune microenvironment

Extracellular vesicles reshape the tumor microenvironment to improve cancer immunotherapy: Current knowledge and future prospects

Extracellular vesicles remodel tumor environment for cancer immunotherapy

Extracellular vesicles derived from immune cells: Role in tumor therapy

The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response

Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies

Extracellular vesicles and the regulation of tumor immunity: Current progress and future directions

Role of Extracellular Vesicles in Tumour Microenvironment

Extracellular vesicles in the tumor microenvironment: old stories, but new tales

Tumor endothelial cell-derived extracellular vesicles contribute to tumor microenvironment remodeling

Extracellular Vesicles (evs) in Tumor Diagnosis and Therapy

Advances and challenges in clinical applications of tumor cell-derived extracellular vesicles

Extracellular vesicles: A dive into their role in the tumor microenvironment and cancer progression

Extracellular Vesicles: A New Perspective in Tumor Therapy

The role of tumor-derived extracellular vesicles containing noncoding RNAs in mediating immune cell function and its implications from bench to bedside

The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond

Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy

Tumor Microenvironment Modulation by Cancer-Derived Extracellular Vesicles

Extracellular vesicle-mediated crosstalk in tumor microenvironment dominates tumor fate